Home Combat Arthritis Why Aclaris Therapeutics Stock Skyrocketed More Than 200% Today Why Aclaris Therapeutics Stock Skyrocketed More Than 200% Today Victor Castaneda Jan 27, 2021 comments off Tweet on Twitter Share on Facebook Google+ Pinterest Why Aclaris Therapeutics Stock Skyrocketed More Than 200% Today Investors are excited about the biotech’s clinical trial results. Read More… arthritis combat arthritis